Dr. George Daley, Co-Chair
Dr. George Daley is director of Stem Cell Transplantation at the Children's Hospital and Dana Farber Cancer Institute, The Samuel E. Lux IV Chair in Hematology, and associate professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. Dr. Daley's lab was among the first to produce human induced pluripotent stem cells and disease-specific stem cells. As a clinician-scientist, Dr. Daley has extensive experience in translating promising science into novel therapeutics.
Dr. Deepak Srivastava, Co-Chair
Dr. Deepak Srivastava is the director of the Gladstone Institute of Cardiovascular Disease, a professor of the departments of Pediatrics and Biochemistry and Biophysics, and Wilma and Adeline Pirag Distinguished Professor in Pediatric Developmental Cardiology at the University of San Francisco (UCSF). Dr. Srivastava’s research focuses on understanding the causes of heart disease and on using knowledge of cardiac developmental pathways to devise novel therapeutics for human cardiac disorders.
Dr. Douglas Melton
Dr. Douglas Melton is co-director of the Harvard Stem Cell Institute, and the Thomas Dudley Cabot Professor in the Natural Sciences at Harvard University. A world authority in developmental biology, pancreatic development, and metabolic disease, Dr. Melton recently published successful in-vivo reprogramming of adult mice exocrine pancreatic cells into insulin secreting cells without reversion to a pluripotent stem cell state.
Dr. Corey Goodman
Dr. Corey Goodman was a professor at Stanford University and the University of California, Berkeley and is currently an adjunct professor at UCSF in the Departments of Anatomy and Biochemistry. While on the faculty at Berkeley, he was an investigator with the Howard Hughes Medical Institute, Evan Rauch Professor of Neuroscience, co-founder of the Wills Neuroscience Institute, and head of the division of neurobiology. Dr. Goodman also is a member of the National Academy of Sciences and was chairman of the National Research Council’s board on Life Sciences, which issued in 2002 the landmark national report “Stem Cells and the Future of Regenerative Medicine."
Dr. Lee Rubin
Dr. Lee Rubin is director of Translational Medicine at the Harvard University Stem Cell Institute. His research has focused on identifying therapeutics for disorders such as SMA, ALS, Huntington's Disease and multiple sclerosis using novel stem cell-based screens and assays.
Dr. Lennart Mucke
Dr. Lennart Mucke is the director and senior investigator of the Gladstone Institute of Neurological Disease, and a professor of Neurology and Neuroscience at UCSF. His research focuses on processes that result in memory loss and other major neurological deficits, with an emphasis on Alzheimer’s disease and related neurodegenerative disorders.
Dr. Matthias Hebrok
Dr. Matthias Hebrok, Hurlbut-Johnson Distinguished Professor in Diabetes Research, is professor of Medicine and associate director for research at the Diabetes Center at UCSF. The main focus of his lab is to understand how islets of Langerhans, the endocrine component of the pancreas, are formed during organogenesis, how their function is regulated in the mature organism, and how changes in gene expression might allow islet regeneration.
Dr. Benoit Bruneau
Dr. Benoit Bruneau is associate investigator at the Gladstone Institute of Cardiovascular Disease and associate professor in the department of Pediatrics at UCSF, and is an expert in cardiac differentiation. Dr. Bruneau’s research focuses on the transcriptional regulation of heart development.
Dr. Kevin Eggan
Dr. Kevin Eggan, is assistant professor in the Department of Stem Cell and Regenerative Biology at Harvard University, principal investigator at the Harvard Stem Cell Institute, and assistant investigator at the Stowers Medical Institute. Dr. Eggan is a world authority on somatic cell reprogramming by nuclear transfer, and the applications of iPS cells to model neurodegenerative disease.
Dr. Amy Wagers
Dr. Amy Wagers is assistant professor in the Section on Developmental and Stem Cell Biology at Joslin Diabetes Center and the Department of Stem Cell and Regenerative Biology at Harvard University, and principal faculty member of the Harvard Stem Cell Institute. Dr. Wagers is a leading expert in adult stem cells of skeletal muscle and bone marrow.